Connect with us

Business

HempAmericana Inc. (OTCMKTS:HMPQ) Due For A Bounce Back As Sentiments Turn Bullish

Published

on

HempAmericana Inc. (OTCMKTS: HMPQ) might as well have served groundbreaking catalysts set to trigger a rally from the current lows. Immediate reports indicate the company has commenced the processing of 4,100 Hemp Flower at one of its production facility. The management has since reiterated it expects CBD distillate output to exceed $1 million. In addition to the $1 million revenue opportunity, HempAmericana sentiments in the market have also received a significant boost in the market. Equity research firm SeeThruEquity has initiated coverage of the stock with a share price target of $0.03. HempAmericana has also refined its production line in the recent past with the installation of two crucial equipment. The installation paves the way for the company to commence production and bottling of refined high-potency CBD oil.

HempAmericana Price Analysis

Recent development appears to have triggered renewed investor interest in the stock if recent price action activity is anything to go by. The stock has since held steady above the $0.01 mark, after coming under immense short selling pressure. A high turnover in traded share in the market could point to a potential break out of the $0.01 mark, backed by strengthened underlying fundamentals. After underperforming for the better part of the year, HempAmericana needs to rise and stabilize above the $0.02 mark to turn bullish.

Above the $0.02 mark, the stock could make a run for the $0.03 mark as alluded by SeeThruEquity Research. Below the $0.01 mark, the stock remains susceptible to further declines given that short sellers remain in firm control in line with the long-term bear trend. However, the stock remains well positioned to surge as underlying fundamentals have improved a great deal in recent weeks.

Catalysts Fuelling Upward Momentum

Hemp Processing Milestone

HempAmericana has revitalized investor interest in the stock on announcing it has started processing 4,100 lbs. of in-house Hemp flower at its extraction and processing facility in Augusta Maine. In line with the processing spree, HempAmericana has confirmed it is in the process of installing two crucial equipment’s. Installation of the equipment will pave the way for the company to start bottling refined, high potency CBD oil as it seeks to enter the distribution and sale business. “We are now ready to put the final pieces into place in terms of our in-house production equipment. We are already up and running, and now we will have the capability to produce the highest-quality CBD product on the market,” said Salvador Rosillo, HempAmericana CEO.

$0.03 Price Target

The harvesting drive, as well as a move to produce high potency CBD oil, has not only caught the attention of investors but as well as equity research firm SeeThruEquity. The firm has since reaffirmed that the stock could be headed to the $0.03 mark, on the company reiterating growth prospects. The research firm has especially taken point of the fact that the company is in the process of completing a 17,000 square foot facility in Maine. The facility once complete will allow the company to produce and process high purity CBD oil. The fact that the company has already started investing in commercialization efforts also indicates HempAmericana readiness to transition into a revenue-generating entity. The CBD market is set to reach $2.1 billion in annual revenue by 2020 thus presenting unique opportunities for the company

Bottom Line

While HempAmericana is still a speculative cannabis play, it has shown it has what it takes to capitalize on the burgeoning legal cannabis hemp market. The company projecting revenues of more than $1 million with the current harvest is a development that attests to robust growth. That said the stock looks set to power out of the current tight trading range on strengthening investor interest. The stock rallying and stabilizing above the $0.02 mark should reaffirm its credential as a long-term play.

Business

Kushco Holdings Inc. (OTCMKTS:KSHB) Reaffirms Its F2019 Revenue Estimate Of Between $145 Million And $150 Million

Published

on

KushCo Holdings Inc. (OTCMKTS:KSHB) has reconfirmed its annual revenue guidance for the fiscal year that ended August 31, 2016, of around $145million to $150 million in sales.

Major milestones and initiatives in 2019

KushCo made significant milestones in fiscal 2019 after it launched several major initiatives. The company rebranded and changed its name to “KushCO Holdings Inc.” with its main operating subsidiary now being Kush Supply Co. It also opened new corporates headquarters in Cypress California.

The company opened a regional distribution center in Taylor Michigan and a product sourcing office in China. The company has enjoyed efficiencies and cost-cutting across its business thanks to the implementation of a new Warehouse Management System across the various warehouse locations.

In a bid to enhance its growth, KushCo joined the Sustainable Packaging Coalition and partnered with Sungrown and IEKO. This will enable it to provide combustible products to its growing consumer base. They also partnered with CA Fortune to introduce retail services to CBD and Hemp brands. KushCo also secured credit facility with Monroe Capital of around $50 million, which is the first for a cannabis company.

KushCo’s long term strategy focuses on creating more value for its customers

KushCO CEO and Chairman, Nick Kovacevich, stated that besides the significant milestones and the transformative initiatives; they have managed to equally grew their business, thus effectively positioning themselves for success. He said that KushCo’s revenue growth for the fiscal year remained strong.

The CEO indicated that the company is currently in a better position, and they are excited about it. He said that KushCO currently has the right people, customer base as well as a growth strategy to enable them to expand. Kovacevich affirmed that they are growing and executing because of the work they have put in establishing a foundation and their optimal long-term strategy, focusing on the creation of value to customers.

Cannabis businesses are partnering with KushCo because of the value they present. Kovacevich stated that they would continue doing everything to create more value for customers and remain key to their success.

Continue Reading

Business

The Wait Is Over For MedMen Enterprises Inc.’s (OTCMKTS:MMNFF) Proposed Acquisition Of PharmaCann

Published

on

MedMen Enterprises Inc. (OTCMKTS:MMNFF) has announced the expiry of the waiting period concerning the proposed acquisition of PharmaCann under the HSR Act. The expiry of the waiting period under the act fulfills the condition necessary to finalize the transaction.

Acquisition to enhance MedMen’s geographical footprint

MedMen CEO and co-founder, Adam Bierman stated that this is a significant step in the cannabis industry. He said that he was optimistic that it would open the way for other companies in what is seen as a highly dynamic and acquisitive industry.

The CEO further affirmed that MedMen had created a desirable footprint which has positioned its brand among the best in the biggest cannabis market in the globe. He added that the acquisition of PharmaCann would make MedMen be even a bigger brand for consumers. With the acquisition, MedMen now doubles the number of states where it currently holds licenses. This further extends the company’s geographic footprint as well as creates a massive opportunity for MedMen shareholders. Bierman concluded by saying that they are delighted they are almost closing the transaction.

MedMen entered an agreement to acquire PharmaCann last year

The company announced in December last year that it had entered into a definitive business combination deal to acquire PharmaCann. In March this year per the HSR Act, the companies received a “Second Request” from the Antitrust Division in the Department of Justice. On August 9 PharmaCann and MedMen confirmed significant compliance with the request for additional information. The waiting period, according to the HSR Act expired on September 9, 2019. The period automatically extended for 30 days following the declaration of substantial compliance by the companies with the Second Request.

According to the terms of the transaction, PharmaCann stockholders will receive around 168.4 million shares of the combined company. This will be based on MedMen’s fully-diluted outstanding shares as of June 29, 2019. However, the total stock is subject to adjustment depending on the company’s fully-diluted outstanding stock as of the date of closing the transaction.  

Continue Reading

Business

Valens Groworks Corp (OTCMKTS:VGWCF) Enters Five Year Contract With Iconic Brewing For Production Of Cannabis-Infused Beverages

Published

on

Valens GroWorks Corp (OTCMKTS:VGWCF) has announced that it has signed a binding five-year white label cannabis beverage deal with Iconic Brewing’s cannabis division. Iconic Brewing is one of Canada’s best innovative beverage companies.

Iconic Brewing to produce 2.5 million cannabis-infused beverages

The white label contract requires Valens to provide Iconic with formulation services, top quality extracts, as well as SoRSETM emulsion solution for its cannabis-infused drinks. On its part, Iconic Brewing will have the obligation of branding and marketing the final products across Canada.

According to the terms of the agreement, the company should produce at least 2.5 million cannabis-infused beverages over five years. There is an option of expanding the partnership with new product offerings soon.

Valens CEO, Tyler Robson indicated that the partnership with Iconic Brewing is a major milestone for Valens. This is because Iconic Brewing is among the fastest-growing beverage companies in eastern Canada, and therefore they will be vital in helping Valens in the creation of a new product line of cannabis-infused beverages.

Valens and Iconic Brewing seeks to leverage each other’s strength in production

Robson lauded the ability of Iconic Brewing to formulate and predict trends which he said are second to none. This is evident from the success of their current beverage products enjoy. Their offerings include Picnic Wine Co, Liberty Village, Cottage Springs Vodka Soda, and Cabana Coast. The CEO added that for Valens to service the agreement, it will employ its proprietary emulsion solution SoRSETM Technology. The technology creates oil-based ingestible products as well as beverages that offer a steady experience with quick onset and offset.

Iconic Brewing’s head of cannabis division, Cole Miller stated that they were delighted to partner with Valens to create a new product line of cannabis-infused drinks. He affirmed the company’s unwavering dedication to enhancing the safe and reliable experience for new cannabis users through their low dosage and unparalleled product education. He added that with the proprietary emulsion technology of Valen, they are ready to deliver their promise of creating the world’s best cannabis-infused beverages.

Continue Reading
Advertisement

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Trade


FEATURED STORIES

Business6 hours ago

Kushco Holdings Inc. (OTCMKTS:KSHB) Reaffirms Its F2019 Revenue Estimate Of Between $145 Million And $150 Million

Post Views: 60 KushCo Holdings Inc. (OTCMKTS:KSHB) has reconfirmed its annual revenue guidance for the fiscal year that ended August...

Business6 hours ago

The Wait Is Over For MedMen Enterprises Inc.’s (OTCMKTS:MMNFF) Proposed Acquisition Of PharmaCann

Post Views: 120 MedMen Enterprises Inc. (OTCMKTS:MMNFF) has announced the expiry of the waiting period concerning the proposed acquisition of...

Business1 day ago

Valens Groworks Corp (OTCMKTS:VGWCF) Enters Five Year Contract With Iconic Brewing For Production Of Cannabis-Infused Beverages

Post Views: 194 Valens GroWorks Corp (OTCMKTS:VGWCF) has announced that it has signed a binding five-year white label cannabis beverage...

Business1 day ago

Supreme Cannabis Company Inc.’s (OTCMKTS:SPRWF) Subsidiary 7ACRES Launches New Strain Jack Haze

Post Views: 110 Supreme Cannabis Company Inc. (OTCMKTS:SPRWF) has announced that its wholly-owned subsidiary 7ACREA has unveiled a new strain...

Business2 days ago

Acasti Pharma Inc. (NASDAQ:ACST) Receives Funding From NRC IRAP For Expanding Production Capability

Post Views: 117 Acasti Pharma Inc. (NASDAQ:ACST) has announced that it has received around $750,000 in a non-dilutive and non-repayable...

Business2 days ago

Auxly Cannabis Group Inc. (OTCMKTS:CBWTF) Receives Cannabis Oil Licenses for Kolab Project and Dosecann

Post Views: 171 Auxly Cannabis Group Inc. (OTCMKTS:CBWTF) has announced that its wholly-owned subsidiaries Kolab Projects Inc. and Dosecann Inc....

Business3 days ago

Innovative Industrial Properties Inc. (NYSE:IIPR) Enters lease agreement with Ascend Holdings In Illinois and Vertical In California

Post Views: 182 Innovative Industrial Properties Inc. (NYSE:IIPR) has announced that it has signed an amendment of the lease with...

Business3 days ago

Trulieve Cannabis Corp (OTCMKTS:TCNNF) Announce The Opening Of retail Location In Port Charlotte

Post Views: 222 Trulieve Cannabis Corp (OTCMKTS:TCNNF) will on Friday, September 13 open doors of a new dispensary as the...

Business4 days ago

Green Thumb Industries Inc. (OTCMKTS:GTBIF) To Open A Seventh RiseTM Retail Location In Pennsylvania

Post Views: 193 Green Thumb Industries Inc. (OTCMKTS:GTBIF) the owner of RiseTM and Essence retail stores has announced that on...

Business4 days ago

Curaleaf Holdings Inc. (OTCMKTS:CURLF) Obtains Approval For Recreational Use Licenses And Launches Medical Cannabis Tablets In Florida

Post Views: 142 Curaleaf Holdings Inc. (OTCMKTS:CURLF) has announced that it has received approval for its three final and two...

Whats Hot

Create a future where the human body can repair, restore, and rejuvenate itself

 

Trading Symbol

OTC: PLSI

The Next Big Global Cannabis Play